Navigation Links
Four Out of Five BioSpain 2012 Participants Identified Genuine Business Opportunities
Date:3/5/2013

MADRID, March 5, 2013 /PRNewswire/ --

A survey reveals visitor satisfaction of 93%, while 97% would be interesting in attending future editions of the fair.

BioSpain 2012, held in Bilbao in September 2012, has strengthened its position as the principal platform for creating business opportunities in Spain's biotechnology sector. A survey by the organisation reveals that 77% of BioSpain 2012 participants identified genuine business opportunities at the event. This aligns with the objectives established by the organisation, which aims for BioSpain to drive the industry in the current adverse economic situation.

As regards general satisfaction, 93% rated the event positively and 88% stated that it had met their expectations; networking was the most highly-valued activity. In fact, partnering at this year's three-day event led to a record 2,775 one-on-one meetings, making it the fifth-largest international event of its type in terms of networking.

Moreover, 97% of those meetings are expected to lead to a second meeting at a later date. Partnering and one-on-one meetings at BioSpain are increasingly viewed as positive because of the technology available to participants; this year more than 643 technologies and products were on offer (22% more than at the previous edition, in 2010).

The survey also provides useful information regarding biotechnology firms' priorities in this adverse economic environment. The main objective of 48% of BioSpain 2012 participants was to identify R&D collaboration opportunities. Other goals were to attract potential clients (46%), learn about the latest trends and technology (32%) and study the competition (26%).

With respect to the future, 97% of participants will consider attending the next edition of BioSpain in 2014 (venue to be determined).

Click on the link below for the survey results:

SOURCE BioSpain 2012 Committee Organization
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioSpain 2012 is Larger in Terms of Internationalisation and the Number of Exhibitors, Meetings and Visitors
2. CAS Names 2012 SciFinder® Future Leaders in Chemistry Program Participants
3. Carin Grings remains identified by researchers at Uppsala University
4. Genuine Bio-Fuel Clears the Air About Biodiesel In Wake of Recent Turmoil
5. Genuine Bio-Fuel Inc. Notes Sustainable Energy Gets A Much Needed Boost from the President Obama During 2013 Inaugural Address
6. Genuine Bio-Fuel Inc. Expands Operations to Puerto Rico
7. Bentley Receives $1.3M to Advance the Integration of Science and Business
8. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
9. BIOCOM Names Rick Fultz Vice President of Business Development
10. Pamlab Announces Agreement for Sale of Business to Nestle Health Science
11. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Follow us on LinkedIn –Cholesterol ... cholesterol carrier or lipoprotein in the blood. Such tests ... in the body, especially along the walls of blood ... other cardiovascular disorders. Cardiovascular Diseases (CVD) is the leading ... on a regular basis, to assess an individual’s risk ...
(Date:9/30/2014)... 2014 CORD:USE Cord Blood Bank – ... has entered into an Equity and Exclusive Services Agreement ... series of patented technologies for the isolation of human ... Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing that ...
(Date:9/30/2014)... 30, 2014 Genedata, a ... drug discovery and related life science research, ... chosen Genedata Selector as its host-pathogen data ... FUNGITECT is a European consortium dedicated to ... via individualized anti-fungal drug therapies. Genedata Selector ...
(Date:9/30/2014)... 30, 2014  KemPharm, Inc., a clinical-stage specialty ... of proprietary new molecular entity (NME) prodrugs, announced ... Office (USPTO) issued U.S. Patent No. 8,816,083 to ... Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates ... Thereof." The patent, which extends through ...
Breaking Biology Technology:Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2
... , ST. LOUIS, Aug. 7 KV Pharmaceutical Company ... owners of the Company,s Class A and Class B Common Stock, ... by written consent purported to have been taken by such Reporting ... of the Company,s By-Laws and is therefore invalid and not effective. ...
... , , BOTHELL, Wash., Aug. ... today reported financial results for the three and six months ended ... Bruce Morra, SCOLR Pharma,s President and CEO, said, "We continue to ... controlled release ibuprofen. These potential partners have been committing resources to ...
... , , , , ... 2Q09 Corporate Highlights: , , ... treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination ... agreement with Astellas Pharma Europe Ltd. (Astellas) for commercialization of Qutenza in Europe, ...
Cached Biology Technology:KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 2KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 3KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 4KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 5KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 6SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 8NeurogesX Reports Second Quarter 2009 Results 2NeurogesX Reports Second Quarter 2009 Results 3NeurogesX Reports Second Quarter 2009 Results 4NeurogesX Reports Second Quarter 2009 Results 5NeurogesX Reports Second Quarter 2009 Results 6NeurogesX Reports Second Quarter 2009 Results 7NeurogesX Reports Second Quarter 2009 Results 8NeurogesX Reports Second Quarter 2009 Results 9NeurogesX Reports Second Quarter 2009 Results 10NeurogesX Reports Second Quarter 2009 Results 11NeurogesX Reports Second Quarter 2009 Results 12
(Date:9/30/2014)... to know what goes wrong with your muscles because of ... what "normal" actually is. That,s where a new research report ... FASEB Journal comes in. In the report, a ... molecules that can help scientists "see" which genes are active ... found never-before-detected gene activity and that men have approximately 400 ...
(Date:9/30/2014)... Sept. 30, 2014  Spectra Automation, a ... the biotech and power generation industries, announced ... Bioprocess Manager, an easy-to-use and cost-effective data ... bioprocess development laboratories. Most ... and analyzer systems. Accessing and consolidating data ...
(Date:9/30/2014)... Winners of The Economist,s prestigious Innovation awards 2014 will ... at the JW Marriott Hong Kong on Friday, October 10 th ... experiences and the lessons those hold for others. The awards, which ... past decade, will be presented at a ceremony in ... be the first time the ceremony has come to ...
Breaking Biology News(10 mins):Scientists identify which genes are active in muscles of men and women 2Spectra Automation Introduces RECONN Bioprocess Manager 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... try savoring the scent of lemon, mango, lavender, or ... first scientific evidence that inhaling certain fragrances alter gene ... stress levels. Their study appears in ACS, Journal ... In the new study, Akio Nakamura and colleagues ...
... Applying biological molecules from cell membranes to ... on the very basics of cell-to-cell interaction. ... Oregon biophysicist and colleagues suggest that putting lipids ... could lead to new classes of self-assembling materials ...
... allows farmers to harvest rice earlier, giving them more time ... and ease hunger during monga -- the hunger months. ... from September to November after the previous season,s food has ... December. According to the Bangladesh Bureau of Statistics, ...
Cached Biology News:New windows opened on cell-to-cell interactions 2New windows opened on cell-to-cell interactions 3Early rice harvests ease annual famine in Bangladesh 2
... Lambda Protein Phosphatase ( ... protein phosphatase with activity ... and tyrosine residues. It ... product of the ORF221 ...
Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni...
Biology Products: